Blynksolve named Emerging Company of the Year 2025
Blynksolve is proud to announce that we have been named Emerging Company of the Year at the BioPharmaChem Ireland Awards 2025, a prestigious recognition that celebrates excellence, innovation, and growth in the biopharma industry.
Recognizing Excellence in Pharmaceutical Manufacturing
The awards, held at the BPC Impact 2025 event in Naas, brought together leading organizations in the biopharma sector. Blynksolve stood out for its transformative impact on pharmaceutical manufacturing, leveraging digital twin technology and real-time data analytics to enhance operational efficiency.
Peter Blennerhassett, CEO of Blynksolve, expressed pride in the team’s dedication:
What a day! It’s an absolute honor for Blynksolve to be recognized alongside so many incredible companies. This award is a testament to the hard work and dedication of our team, whose commitment to innovation has made this possible.
Selection Criteria
The Emerging Company of the Year Award recognizes companies demonstrating:
- Strategic Vision
- Innovation and Technology Excellence
- Strong Customer Focus
- Clear Commercial Impact
Blynksolve's work with blynkInsights, a powerful solution for real-time process monitoring and optimization, was highlighted as a key factor in our selection.
Building on Our Success
This recognition follows Blynksolve’s Innovation of the Year win at the Pharma Industry Awards 2023, further solidifying our position as a leader in digital transformation for the pharmaceutical sector.
Read more about the BioPharmaChem Impact Awards 2025: https://www.ibec.ie/connect-and-learn/industries/life-sciences-and-healthcare/biopharmachem-ireland/about-bpci/biopharmachem-impact-awards